Evidence map›Paper›PMID 28239510›Full record

ArticleJournal of anesthesia & clinical research2017

Lidocaine Infusion: A Promising Therapeutic Approach for Chronic Pain.

Enas Kandil, Emily Melikman, Bryon Adinoff

3 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Journal of anesthesia & clinical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04931433 phase4completednot on this mapstarted 2020, after this paper: background citation

Intravenous Lignocaine as an Analgesic Adjunct in Adolescent Idiopathic Scoliosis Surgery (IGNITE-AIS Study)

TypeinterventionalSponsorUniversity of MalayaRan2020 to 2022Enrolled115ConditionsAdolescent Idiopathic Scoliosis, AnalgesiaArmsLignocaine, Normal saline
NCT06249113 nacompletednot on this mapstarted 2023, after this paper: background citation

Effectiveness of Adjuvant Continuous Lidocaine in General Anesthesia on Depth of Anesthesia (qCON), Pain Response (qNOX), and Blood Sugar Levels in Elective Primary Tumor Craniotomy Surgery

TypeinterventionalSponsorIndonesia UniversityRan2023 to 2024Enrolled60ConditionsSurgery, Anesthesia, Functional, Haemodynamic InstabilityArmsNaCl 0.9%, Adjuvant lidocaine continous
NCT07408193 early_phase1recruitingnot on this mapstarted 2026, after this paper: background citation

The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain: a Randomized, Double-Blinded, Placebo-Controlled, Cross-Over Trial.

TypeinterventionalSponsorNational and Kapodistrian University of AthensRan2026 to 2027Enrolled24ConditionsOpioid-Refractory Chronic Cancer-Related PainArmsLidocaine and Ketamine Infusion, Active Placebo (Midazolam) Infusion
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Identification of tetracycline combinations as EphB1 tyrosine kinase inhibitors for treatment of neuropathic pain.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Enas KandilDepartment of Anesthesiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Emily MelikmanDepartment of Anesthesiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Bryon AdinoffDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
The University of Texas Southwestern Medical Center · US

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1KL2TR001103 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$4.0M
NCATS NIH HHS KL2 TR001103NCATS NIH HHS UL1 TR001105
6 · The paper itself

Abstract

Opioid abuse is a national epidemic in the United States, where it is estimated that a prescription drug overdose death occurs every 19 minutes. While opioids are highly effective in acute and subacute pain control, their use for treatment of chronic pain is controversial. Chronic opioids use is associated with tolerance, dependency, hyperalgesia. Although there are new strategies and practice guidelines to reduce opioid dependence and opioid prescription drug overdose, there has been little focus on development of opioid-sparing therapeutic approaches. Lidocaine infusion has been shown to be successful in controlling pain where other agents have failed. The opioid sparing properties of lidocaine infusion added to its analgesic and antihyperalgesic properties make lidocaine infusion a viable option for pain control in opioid dependent patients. In this review, we provide an overview of the opioid abuse epidemic, and we outline current evidence supporting the potential use of lidocaine infusion as an adjuvant therapeutic approach for management of chronic pain.

Indexed as

Choice of hospitalHip replacementKnee replacementPatient expectationsSurgery

Identifiers

PMID28239510
PMCPMC5323245
OpenAlexW2586208579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.